{"id":"phenpromethamine","rwe":[],"tags":[{"label":"phenpromethamine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"vonedrine","offLabel":[],"synonyms":["phenylpropylmethylamine","N-Methyl-2-phenylpropylamine","phenpromethamine","vonedrine"],"timeline":[],"approvals":[],"brandName":"Vonedrine","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"phenpromethamine","explanation":"Imagine your brain is a computer, and Vonedrine is a software update that makes it run faster and more efficiently. This can help increase alertness and energy, but it can also have negative effects if not used carefully. The exact way Vonedrine achieves this effect is not fully understood, but it is thought to involve changes in the levels and activity of certain chemicals in the brain.","oneSentence":"Vonedrine works by interacting with the body's central nervous system to produce a stimulant effect.","technicalDetail":"Vonedrine is a phenpromethamine, a class of compounds that act as central nervous system stimulants by increasing the release of certain neurotransmitters, such as dopamine and norepinephrine, and blocking the reuptake of others, such as serotonin."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3461","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=PHENPROMETHAMINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:18:47.262195","biosimilars":[],"competitors":[],"genericName":"phenpromethamine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"001801","UNII":"7D4542I59V","CHEBI":"CHEBI:134771","INN_ID":"139","UMLSCUI":"C5238206","ChEMBL_ID":"CHEMBL1622886","PUBCHEM_CID":"22276","SNOMEDCT_US":"27822002"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Neuroscience"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Vonedrine, also known as PHENPROMETHAMINE, is a small molecule drug in the phenpromethamine class. Its exact target and mechanism of action are unknown, and it has not been approved by the FDA for any indications. The commercial status of Vonedrine is unclear, and it is not known whether it is patented or available as a generic. As a result, key safety considerations and pharmacokinetic properties, such as half-life and bioavailability, are also unknown. Further research is needed to fully understand the properties and potential uses of Vonedrine.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}